Our goal is build the world’s largest genetic data ecological chain and a global genome data hub.

More team and project information, please refer to our official website, thanks. https://www.xgenomics.org

   
What is X Genomics?

X Genomics is a project combining gene technology with blockchain technology. It will break the silos of industry information and integrate the human genome data on a blockchain by building a global genetic data hub and opening a transparent service platform for sharing human genome data. It will integrate and attract various gene technologies and scientific research institutions to participate in genetic data analysis and mining. It will maximize the value of genetic data, and provide comprehensive, customized health management and life guidance for gene donors. Meanwhile, it will develop various application scenarios for genetic data, enabling the genetic data to be widely used in human economic and social activities.

How it Works

X Genomics will integrate various gene technologies and attract scientific research institutions to participate in genetic data analysis and mining. It will maximize the value of genetic data, and provide comprehensive, customized health management and life guidance for gene donors. Meanwhile, it will develop a range of various application scenarios for genetic data, enabling the genetic data to be widely used inhuman economic and social activities.


Professional Team

   Randy Schekman

   -      Winner of 2013 Nobel Prize in Physiologyor Medicine
   -      Winner of Gairdner Foundation International Award
   -      Winner of Albert Lasker Award for Basic Medical Research
   -      Winner of Louisa Gross Horwitz Prize
   -      Winner of Massry Prize
   -      American Cell Biologist
   -      Academician of the United States National Academy of Sciences
   -      Foreign Members of the RoyalSociety
   -      Professor at the University of California, Berkeley
   -      Former Editor-in-chief ofProceedings of the National Academy of Science
   -      Current Editor in eLife

   Eric Maskin
        
   -      Winner of 2007 Nobel MemorialPrize in Economic Sciences
   -      Winner of the James Joyce Award
   -      Winner of the Louis M. Brown Award
   -      American Economist , Most Respected Master of Economics in International Economics Today
   -      Economics and Mathematics Professor at Harvard University
   -      Visiting Professor at Massachusetts Institute of Technology
   -      Professor at School of Social Sciences of the Institute for Advanced Study
   -      Presidents of the Econometric Society
   -      Presidents of the Game Theory Society
   -      Academician of British Academy of Sciences
   -      Academician of American Academy of Arts and Sciences

   Sabeeha Merchant

   -      Distinguished Professor of Chemistry and Biochemistry at UCLA
   -      Director of the Institute for Genomics and Proteomics
   -      Academician of the U.S National Academy of Sciences
   -      Academician of American Academy of Arts and Sciences
   -      Academician of Germany Academy of Sciences
   -      Winner of Gilbert Morgan Smith Medal
   -      Winner of National Institutes of Health Research Career Development Award
   -      Winner of UCLA Faculty Career Development Awards
   -      Winner of Charles Shull Award
   -      Winner of Herbert Newby McCoy Award
   -      Editor-in-Chief of the Plant Cell and the Annual Reviews of Plant Biology

Token Distribution
   
To support the development of the X Genomics, the X Genomics blockchain will launch a token sale. The supply of native X Genomics tokens(GSX) totals 1 billion (1,000,000,000). Tokens will be distributed as ERC-20 compatible tokens after token sale ends.

   35% for the token sale

   25% toward the foundation to be used for ecosystem-building and development

   15% to the team & advisors

   10% toward the community to be used as incentives in the ecosystem

   5% to the angel investor

When will the next airdrop?

I seem to miss a good project

 I think that BRM needs the system of the price value increasing.